Glaucoma is an eye disease and a leading cause of blindness. The optic nerve is injured. The intra-ocular pressure is increased

Mentor Capital Seeds Glaucoma – Cannabis Venture \\ Contract Signed for Medical Marijuana Application to Glaucoma

April 13, 2017

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announces it has initiated funding for its GlauCanna venture for the use of medical marijuana in the treatment of glaucoma patients.  Mentor will provide funding and business management for any commercial development and holds an 80% interest. Dr. Robert M. Mandelkorn, an ophthalmologist specializing in glaucoma, holds 20% […]

Mentor Capital Gains 4,000 Shareholders During First Quarter \\ Cannabis M&A Leader Provides Public Market Based Liquidity and Cash for Larger Medical Marijuana Operators

April 07, 2017

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announced it has continued adding over 1,000 shareholders per month bringing its base of active shareholders who have Mentor shares in a brokerage account to 10,000 from 6,000 just at year end and 3,000 only three months earlier. “This extraordinary strong shareholder base allows Mentor to provide an […]


Mentor Capital Invests First $1.0 Million in G FarmaLabs \\ Cannabis Market Leader Picks Mentor for Sophisticated Funding Program

March 23, 2017

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announces it has closed and paid in cash and stock a $1.0 million multi-faceted financing program for G FarmaLabs Limited.  The initial Mentor financing is structured to provide funding for real estate and working capital.  G Farma has also been provided Mentor public shares to participate in any […]

FBI agent, man working in the office on a crime. He is sitting at his desk and writing.

Mentor Capital Marks Recovery of $15 Million for Shareholders \\ A Long Gradual Mentor Victory for 1,200 Old-Timers in Our Investor Family

March 22, 2017

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) is now closing a long chapter in its history and estimates that has completely recovered $15 million for those 1,200 shareholders that Mentor uncovered had been defrauded by private syndicators before they became Mentor shareholders.  “We brought in the FBI and SEC, eventually sending the kingpin to jail […]

Mentor Capital CEO Contractually Limits His Stock Sales \\ MNTR Stock Price Gains 600% Since August 2016 Contract Limit Set

March 21, 2017

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) CEO, Chet Billingsley reported that since August 15, 2016 he has contractually limited his stock sale orders to a level 13,500 to 16,000 shares in any given week and the Mentor share price rose 600%.  For the preceding thirteen years he had sold zero shares. Since 2014 this […]

Mentor Capital Acquires $1.0 Million of GW Pharmaceuticals, Plc \\ Debt-free Cannabis M&A Leader Deploys Part of $2.5 Million in New Cash

March 03, 2017

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announced it has taken a $1.0 million position in the stock of GW Pharmaceuticals, Plc (NASDAQ: GWPH) a United Kingdom based group developing a portfolio of cannabinoid prescription medicines. Mentor Capital, Inc. CEO, Chet Billingsley explains his investment analysis, “During the last few months Mentor has seen a […]

Marijuana election political issue on the vote ballot as a symbol for cannabis medical use or drug law legislation as a political subject during a campaign.

Mentor Capital CEO Discusses Recent 275% Share Price Increase \\ Positive Outlook for Marijuana Ballot Initiatives Increases Cannabis Sector 33%

October 07, 2016

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) reports that in the last three weeks the overall public cannabis market has reflected approximately a 33% gain.  This appears from popular professional discussion forums to be driven by the investing public speculation on the increasingly positive outlook for the numerous marijuana related ballot and election driven initiatives […]

Delaware Road Sign

Mentor Capital Now a Delaware Company \\ Public Company Incubator Program Supports Quality Medical Marijuana Spinoffs

October 27, 2015

SAN DIEGO, Mentor Capital, Inc. (OTCQB: MNTR) announced that its legal move to Delaware is complete. “Our goal was to establish the legal base for completing securities compliant spinoffs of quality cannabis and medical marijuana companies in a cost effective manner,” explains Mentor CEO, Chet Billingsley. “Delaware has a well codified securities and business law […]


Mentor Capital in Forbes \\ Why Legalizing Medical Marijuana Will Make Investors Extremely Wealthy by Mark Fidelman

November 04, 2014

I never thought I’d see more people invest in marijuana than smoke it. But those investments are exactly what’s about to happen given a recent survey from some of the most influential and social analysts in the BioPharma space.  In fact, according to and our research, two-thirds (2/3) of the analysts love the potential of the marijuana industry since the […]


Mentor Capital Discusses Cannabis Investing at The MoneyShow \\ Generic Marijuana Stock Tips to be Covered Friday at San Francisco Show

August 20, 2014

SAN DIEGO, Mentor Capital, Inc. (OTC Markets: MNTR) announced that it’s CEO, Chet Billingsley, will be discussing what investors might look for and lookout for in the wild west of cannabis investing at The MoneyShow in San Francisco August 21 – 23. “The overall cannabis sector is projected to grow twenty-fold as the more complete […]

Copyright © 2017 Mentor Capital, Inc. All Rights Reserved. | Web Development by BCR Global.